Main > MEDICINE > HyperEosinophilic Syndrome > Treatment > MepolizuMAb (IL-5 Inhibitor) > Co.: UK. G. (Phase III) > UpDate: 03.14.08. (Press Release)

---

This data is not available for free


UpDate: 03.14.08. (Press Release)'s products
This section has no products